pharma · Influenza, Human · Influenza
Seqirus USA
Seqirus (Australia) Pty Ltd
Seqirus USA trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Summit, USA HQ
8 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Summit, USA
- Employees
- 8
- Programs
- 9
- Drugs
- 19
- Patents
- 0
Seqirus USA clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to Seqirus USA programs — each row shows trial ID, program name, phase, status, and indication.
Seqirus USA trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Seqirus USA.
-
V118_18 — Phase 3
Clinical update -
Trivalent influenza vaccine (TIVc) — Phase 2
Clinical update -
Influenza Virus Vaccine — Phase 3
Clinical update -
H5N1 antigen combined with MF59 adjuvant — Phase 2
Clinical update -
CSL Limited Influenza Vaccine — Approved
Clinical update -
Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV) — Phase 3
Clinical update -
QIVc — Phase 3
Clinical update -
Investigational aQIVc — Phase 3
Clinical update